Show simple item record

dc.contributor.authorElshimy, Ghada
dc.contributor.authorCorrea, Ricardo
dc.date.accessioned2019-10-16T16:13:22Z
dc.date.available2019-10-16T16:13:22Z
dc.date.issued2019-08-21
dc.identifier.citationElshimy G, Correa R (August 21, 2019) Sudden-onset Hypoglycemia Following Fluid Replacement in a Patient with Dapagliflozin-induced Diabetic Ketoacidosis Without Prior Insulin Use: Case Report. Cureus 11(8): e5448. doi:10.7759/cureus.5448en_US
dc.identifier.issn2168-8184
dc.identifier.pmid31489272
dc.identifier.doi10.7759/cureus.5448
dc.identifier.urihttp://hdl.handle.net/10150/634768
dc.description.abstractEuglycemic diabetic ketoacidosis (DKA) is a known complication of sodium-glucose co-transporter 2 (SGLT-2) inhibitors that have been reported in the literature. The prevalence of this side effect is growing and the exact mechanism of action on why this happens is unknown. Hypoglycemia events are very rare in diabetic patients using SGLT-2 inhibitors and/or metformin when they have normal kidney function. We report a novel complication of hypoglycemia that occurred during the course of treatment of SGLT2 inhibitor-induced DKA in a patient with type 2 diabetes mellitus (T2DM) on the dapagliflozin-metformin combination.en_US
dc.language.isoenen_US
dc.publisherCUREUS INCen_US
dc.rights© Copyright 2019 Elshimy et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_US
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/
dc.subjectdiabetic ketoacidosisen_US
dc.subjecthypoglycemiaen_US
dc.subjectmetforminen_US
dc.subjectsodium-glucose co transporter-2 (sglt2) inhibitorsen_US
dc.titleSudden-onset Hypoglycemia Following Fluid Replacement in a Patient with Dapagliflozin-induced Diabetic Ketoacidosis Without Prior Insulin Use: Case Reporten_US
dc.typeArticleen_US
dc.contributor.departmentUniv Arizona, Coll Med Phoenix, Endocrinol Diabet & Metaben_US
dc.identifier.journalCUREUSen_US
dc.description.noteOpen access journalen_US
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.en_US
dc.eprint.versionFinal published versionen_US
dc.source.journaltitleCureus
refterms.dateFOA2019-10-16T16:13:22Z


Files in this item

Thumbnail
Name:
1567006974-20190828-218-1snxidr.pdf
Size:
1.783Mb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

© Copyright 2019 Elshimy et al. This is an open access article distributed under the terms of the Creative Commons Attribution
License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Except where otherwise noted, this item's license is described as © Copyright 2019 Elshimy et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.